Safety and Immunogenicity of MSB11455 in Healthy Participants

A Randomized, Double-blind, Parallel Group,Controlled Study to Compare the Immunogenicity and Safety of MSB11455 and Neulasta® in Healthy Adult Subjects

The primary purpose of this study is to compare the immunogenicity and safety of MSB11455 and Neulasta in healthy adult participants.

Inclusion Criteria:

• Participants who provide signed and dated written informed consent.
• Participants with laboratory test results within predefined ranges.
• Other protocol defined inclusion criteria could apply.

Exclusion Criteria:

• Participants with known hypersensitivity to any component of US-Neulasta or MSB11455.
• Other protocol defined exclusion criteria could apply.